Placenta–Brain Axis Disruption in Maternal Preeclampsia: Stereological and Spatial Neurovascular Mapping of Fetal Hippocampal Development

Reyim Hameid Kamel

Authors

Reyim Hameid Kamel Department of Biology, College of Science, University of Al-Qadisiyah

Keywords:

Preeclampsia, Fetal hippocampus, Placenta–brain axis, Stereology, Neurovascular unit, sFlt-1, Pericyte, Aquaporin-4, Neuroinflammation, L-NAME rat model

Abstract

Background: Preeclampsia (PE) is a multisystem hypertensive disorder of pregnancy that imposes far-reaching consequences on fetal neurodevelopment through disruption of the placenta–brain axis. While clinical associations between maternal PE and offspring neurocognitive impairment are well documented, the precise structural and vascular alterations within the fetal hippocampus remain incompletely characterised. Objectives: To quantify stereological parameters—including neuronal number, synaptic density, and glial cell populations—within the fetal hippocampus following maternal PE, and to perform three-dimensional spatial mapping of neurovascular unit integrity across hippocampal subfields. Methods: A validated rat model of PE was induced via continuous systemic administration of Nω-nitro-L-arginine methyl ester (L-NAME) from gestational day (GD) 14 to GD 20. Fetal brains were harvested at GD 20 and postnatal day (PND) 21. Stereological analyses employed the optical fractionator and Cavalieri principle. Spatial neurovascular mapping integrated confocal immunofluorescence of RECA-1, aquaporin-4 (AQP4), platelet-derived growth factor receptor-β (PDGFRβ), and synaptophysin. Placental transcriptomics (RNA-sequencing) and fetal serum cytokine profiling complemented the morphological data. Results: PE dams exhibited significantly elevated systolic blood pressure (163 ± 8 vs. 112 ± 6 mmHg; p < 0.001) with marked proteinuria. Fetal hippocampal pyramidal neuron count was reduced by 34.7% in CA1 and 28.3% in CA3 relative to controls (p < 0.01). Dentate gyrus granule cell density declined by 22.1% (p < 0.05). Synaptophysin immunoreactivity fell by 41.6% in stratum radiatum. Microvessel density decreased 38.9% and pericyte coverage declined 46.2%. AQP4 polarisation at astrocytic endfeet was significantly disrupted. Placental sFlt-1 transcripts were upregulated 5.8-fold; fetal serum IL-6, TNF-α, and VEGF were reciprocally altered. Conclusions: Maternal PE induces a reproducible syndrome of hippocampal hypoplasia, synaptic rarefaction, and neurovascular unit disruption in the fetal brain. The data support a placenta–brain axis model in which anti-angiogenic placental signalling, systemic inflammatory mediators, and impaired fetal cerebral perfusion converge to remodel hippocampal architecture during critical developmental windows.

References

L. Bergman et al., “Investigating maternal brain alterations in preeclampsia: The need for a multidisciplinary effort,” Current Hypertension Reports, vol. 21, no. 9, p. 72, 2019.

A. Bokslag, M. van Weissenbruch, B. W. Mol, and C. J. M. de Groot, “Preeclampsia: Short and long-term consequences for mother and neonate,” Early Human Development, vol. 102, pp. 47–50, 2016.

J. L. Caniglia et al., “Placenta-brain axis: A bidirectional relationship in neurodevelopment,” Neuroscience & Biobehavioral Reviews, vol. 148, p. 105133, 2023.

T. Chaiworapongsa et al., “Pre-eclampsia part 1: Current understanding of its pathophysiology,” Nature Reviews Nephrology, vol. 10, no. 8, pp. 466–480, 2014.

M. E. Coussons-Read, “Effects of prenatal stress on pregnancy and human development: Mechanisms and pathways,” Obstetric Medicine, vol. 6, no. 2, pp. 52–57, 2013.

J. Dalmau and F. Graus, “Antibody-mediated encephalitis,” New England Journal of Medicine, vol. 378, no. 9, pp. 840–851, 2018.

L. Duley, “The global impact of pre-eclampsia and eclampsia,” Seminars in Perinatology, vol. 33, no. 3, pp. 130–137, 2009.

H. J. Gundersen and E. B. Jensen, “The efficiency of systematic sampling in stereology and its prediction,” Journal of Microscopy, vol. 147, no. 3, pp. 229–263, 1987.

H. Hagberg et al., “The role of inflammation in perinatal brain injury,” Nature Reviews Neurology, vol. 11, no. 4, pp. 192–208, 2015.

J. L. Hecht et al., “Relationship of fetal growth restriction and placental pathology,” Placenta, vol. 37, pp. 67–72, 2016.

C. Iadecola and M. Nedergaard, “Glial regulation of the cerebral microvasculature,” Nature Neuroscience, vol. 10, no. 11, pp. 1369–1376, 2007.

S. A. Karumanchi and M. D. Lindheimer, “Preeclampsia pathogenesis: ‘Triple a rating’—Anti-angiogenic proteins and autoantibodies,” Hypertension, vol. 51, no. 4, pp. 991–992, 2008.

R. J. Levine et al., “Circulating angiogenic factors and the risk of preeclampsia,” New England Journal of Medicine, vol. 350, no. 7, pp. 672–683, 2004.

V. A. Luyckx and B. M. Brenner, “Birth weight, malnutrition and kidney-associated diseases,” Nature Reviews Nephrology, vol. 6, no. 9, pp. 565–573, 2010.

S. E. Maynard et al., “Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia,” Journal of Clinical Investigation, vol. 111, no. 5, pp. 649–658, 2003.

T. K. Morgan, “Role of the placenta in preterm birth: A review,” American Journal of Perinatology, vol. 33, no. 3, pp. 258–266, 2016.

A. Muñoz-Morales et al., “Perinatal asphyxia and neurodevelopment,” Neonatology, vol. 115, no. 4, pp. 394–402, 2019.

R. L. Naeye and A. R. Localio, “Determining the time before birth when ischemia and hypoxemia initiated cerebral palsy,” Obstetrics & Gynecology, vol. 86, no. 5, pp. 713–719, 1995.

S. Ornaghi et al., “Placental programming of autism spectrum disorder,” Frontiers in Neuroscience, vol. 15, p. 614800, 2021.

H. Pham et al., “Aquaporin-4 and blood–brain barrier function in perinatal brain injury,” International Journal of Molecular Sciences, vol. 23, no. 6, p. 3040, 2022.

J. M. Roberts and C. A. Hubel, “The two-stage model of preeclampsia: Variations on the theme,” Placenta, vol. 30, suppl. A, pp. S32–S37, 2009.

S. Saito et al., “Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy,” American Journal of Reproductive Immunology, vol. 63, no. 6, pp. 601–610, 2010.

A. B. Salmina et al., “Blood-brain barrier and neurovascular unit in vitro models for studying mitochondria-driven molecular mechanisms of neurodegeneration,” International Journal of Molecular Sciences, vol. 22, no. 8, p. 4089, 2021.

B. M. Sibai, G. Dekker, and M. Kupferminc, “Pre-eclampsia,” The Lancet, vol. 365, no. 9461, pp. 785–799, 2005.

E. A. Steegers et al., “Pre-eclampsia,” The Lancet, vol. 376, no. 9741, pp. 631–644, 2010.

W. Y. Tam et al., “Blood-brain barrier and fetal programming of neurological disease,” Seminars in Fetal & Neonatal Medicine, vol. 26, no. 5, p. 101278, 2021.

R. Trollmann and M. Gassmann, “The role of hypoxia-inducible transcription factors in the hypoxic neonatal brain,” Brain & Development, vol. 31, no. 7, pp. 503–509, 2009.

M. Uhlén et al., “Proteomics: Tissue-based map of the human proteome,” Science, vol. 347, no. 6220, p. 1260419, 2015.

M. J. West, L. Slomianka, and H. J. Gundersen, “Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator,” The Anatomical Record, vol. 231, no. 4, pp. 482–497, 1991.

Y. Zhou, C. H. Damsky, and S. J. Fisher, “Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype,” Journal of Clinical Investigation, vol. 99, no. 9, pp. 2152–2164, 1997.